Brantl, S Annette <br/><br/>
Activation of platelets by the endocannabinoids 2-arachidonoylglycerol and virodhamine is mediated by their conversion to arachidonic acid and thromboxane A2, not by activation of cannabinoid receptors.  [electronic resource] 

 -  Platelets  2014 
 - 465-6 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1369-1635 
<br/><br/><label>Standard No.: </label>10.3109/09537104.2013.835040  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Arachidonic Acids--metabolism<br/>Blood Platelets--metabolism<br/>Cannabinoid Receptor Agonists--metabolism<br/>Cannabinoids--pharmacology<br/>Endocannabinoids--metabolism<br/>Glycerides--metabolism<br/>Humans<br/>Platelet Activation--drug effects<br/>Receptors, Cannabinoid--metabolism<br/>Thromboxane A2--metabolism